You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Details for Patent: 9,629,837


✉ Email this page to a colleague

« Back to Dashboard


Title:Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
Abstract: The present disclosure provides extended release pharmaceutical compositions comprising oxycodone and acetaminophen that produce a quick initial onset of analgesia, yet, maintain analgesia for about 12 hours after administration of the composition to a subject in need thereof. The pharmaceutical compositions disclosed herein also reduce the levels of acetaminophen in a subject's blood near the end of the dosing interval because the acetaminophen released by the pharmaceutical composition is being eliminated by a subject's body faster than it is being absorbed.
Inventor(s): Devarakonda; Krishna (St. Louis, MO), Giuliani; Michael J. (Creve Coeur, MO), Gupta; Vishal K. (Hillsborough, NJ), Heasley; Ralph A. (Webster Groves, MO), Shelby; Susan (Town and Country, MO)
Assignee: MALLINCKRODT LLC (Hazelwood, MO)
Filing Date:Mar 17, 2015
Application Number:14/659,819
Claims:1. A pharmaceutical composition comprising: at least one immediate release portion comprising oxycodone or a pharmaceutically acceptable salt of oxycodone, acetaminophen, or a combination thereof; at least one extended release portion comprising oxycodone or a pharmaceutically acceptable salt of oxycodone, acetaminophen, and an extended release component; wherein the total amount of acetaminophen in the composition is about 325 mg to about 650 mg, and the total amount of oxycodone or salt in the composition is about 7.5 mg to about 15 mg; wherein upon oral administration of the composition to a subject, the composition provides an AUC.sub.0-1h for acetaminophen of about 1.25 ngh/mL/mg to about 3.25 ngh/mL/mg; a mean AUC for acetaminophen of about 35.0 nghr/mL/mg to about 60.0 nghr/mL/mg; an AUC.sub.0-1h for oxycodone or salt of about 0.1 ngh/mL/mg to about 0.45 ngh/mL/mg; and a mean AUC for oxycodone or salt of about 9.0 nghr/mL/mg to about 18.5 nghr/mL/mg; and wherein the subject attains therapeutic blood levels of both the oxycodone and the acetaminophen within about one hour after administration of the composition and maintains analgesia for at least about 10 hours after administration of the composition.

2. The pharmaceutical composition of claim 1, wherein the AUC.sub.0-1.h for acetaminophen is about 1.6 ngh/mL/mg to about 2.0 ngh/mL/mg.

3. The pharmaceutical composition of claim 1, wherein the AUC.sub.0-1h for acetaminophen is about 2.0 ngh/mL/mg to about 2.75 ngh/mL/mg.

4. The pharmaceutical composition of claim 1, wherein the AUC.sub.0-1.h for oxycodone or salt is about 0.15 ngh/mL/mg to about 0.25 ngh/mL/mg.

5. The pharmaceutical composition of claim 1, wherein the AUC.sub.0-1.h for oxycodone or salt is about 0.25 ngh/mL/mg to about 0.35 ngh/mL/mg.

6. The pharmaceutical composition of claim 1, wherein the mean AUC for acetaminophen is about 40.0 ngh/mL/mg to about 50.0 ngh/mL/mg.

7. The pharmaceutical composition of claim 1, wherein the mean AUC for acetaminophen is about 35.0 ngh/mL/mg to about 45.0 ngh/mL/mg.

8. The pharmaceutical composition of claim 1, wherein the mean AUC for oxycodone or salt is about 11.0 ngh/mL/mg to about 17.0 ngh/mL/mg.

9. The pharmaceutical composition of claim 1, wherein the mean AUC for oxycodone or salt is about 12.0 ngh/mL/mg to about 16.0 ngh/mL/mg.

10. The pharmaceutical composition of claim 1, wherein the subject attains therapeutic blood levels of both the oxycodone and the acetaminophen within about 30 minutes after administration of the composition.

11. The pharmaceutical composition of claim 1, wherein the composition comprises about 325 mg of acetaminophen and about 7.5 mg of oxycodone or salt.

12. The pharmaceutical composition of claim 11, wherein the composition is in the form of a tablet and a single dose comprises two tablets.

13. The pharmaceutical composition of claim 1, wherein the extended release component comprises at least one extended release polymer.

14. A pharmaceutical composition comprising: at least one immediate release portion comprising oxycodone or a pharmaceutically acceptable salt of oxycodone, acetaminophen, or a combination thereof; at least one extended release portion comprising oxycodone or a pharmaceutically acceptable salt of oxycodone, acetaminophen, or a combination thereof; wherein the total amount of acetaminophen in the composition is about 325 mg to about 650 mg, and the total amount of oxycodone or salt in the composition is about 7.5 mg to about 15 mg; wherein upon oral administration of the composition to a subject, the composition provides an AUC.sub.0-2h for acetaminophen of about 4.25 ngh/mL/mg to about 8.75 ngh/mL/mg; mean AUC for acetaminophen of about 35.0 nghr/mL/mg to about 60.0 nghr/mL/mg; an AUC.sub.0-2h for oxycodone or salt of about 0.65 ngh/mL/mg to about 1.35 ngh/mL/mg; and a mean AUC for oxycodone or salt of about 9.0 nghr/mL/mg to about 18.5 nghr/mL/mg; and wherein the subject attains therapeutic blood levels of both the oxycodone and the acetaminophen within about one hour after administration of the composition and maintains analgesia for about 12 hours after administration of the composition.

15. The pharmaceutical composition of claim 14, wherein the AUC.sub.0-2h for acetaminophen is about 5.5 ngh/mL/mg to about 6.0 ngh/mL/mg.

16. The pharmaceutical composition of claim 14, wherein the AUC.sub.0-2h for acetaminophen is about 6.0 ngh/mL/mg to about 7.25 ngh/mL/mg.

17. The pharmaceutical composition of claim 14, wherein the AUC.sub.0-2.h for oxycodone or salt is about 0.8 ngh/mL/mg to about 1.0 ngh/mL/mg.

18. The pharmaceutical composition of claim 14, wherein the AUC.sub.0-2.h for oxycodone or salt is about 1.0 ngh/mL/mg to about 1.2 ngh/mL/mg.

19. The pharmaceutical composition of claim 14, wherein the composition comprises about 325 mg of acetaminophen and about 7.5 mg of oxycodone or salt.

20. The pharmaceutical composition of claim 19, wherein the composition is in the form of a tablet and a single dose comprises two tablets.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.